Kimberly-Clark, is acquiring Tylenol's parent company Kenvue in a cash and stock deal worth nearly 50 billion, creating a massive consumer health products company. The Kimberly-Clark conglomerate, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results